CLINICAL_TRIALS
trial_result
· 2024-03-08
Clinical Trial Update: Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea
Summary
Post-marketing surveillance study assessing safety and efficacy of Inlyta in South Korea for advanced renal cell carcinoma; study completed with results posted …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Advanced Renal Cell Carcinoma | Status: COMPLETED | Results posted: 2024-03-08